- Home
- SACH vs TLPH Comparison
SACH vs TLPH Comparison
Compare SACH & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SACH | TLPH |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | United States | United States |
| Employees | 27 | 12 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.9M | 46.6M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | SACH | TLPH |
|---|---|---|
| Price | $1.21 | $0.82 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 441.1K | 146.5K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | ★ 19.23% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | $145.00 | N/A |
| Revenue Next Year | $6.80 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.90 | $0.38 |
| 52 Week High | $1.45 | $1.57 |
Technical Indicators
Market Signals| Indicator | SACH | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 63.65 | 45.45 |
| Support Level | $0.99 | $0.73 |
| Resistance Level | N/A | $0.87 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 52.33 | 16.18 |
Price Performance
Historical ComparisonAbout SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.